Free Float -
Shares Float -
Shares Outstanding 25,65 M
DA32 Life Science Tech Acquisition Corp.
Share · US23312M1062 · DALS (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of DA32 Life Science Tech Acquisition Corp.
No Price
Share Float & Liquidity
Company Profile for DA32 Life Science Tech Acquisition Corp. Share
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Company Data
Name DA32 Life Science Tech Acquisition Corp.
Company DA32 Life Science Tech Acquisition Corp.
Symbol DALS
Primary Exchange 
NASDAQ
NASDAQ
ISIN US23312M1062
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Steven Kafka
Market Capitalization 264 Mio
Country United States of America
Currency USD
Employees -
Address 345 Park Avenue South, 10010 New York City
IPO Date 2021-07-28
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | DALS |
More Shares
Investors who hold DA32 Life Science Tech Acquisition Corp. also have the following shares in their portfolio:
